Hydrocortisone acetate 30 MG Rectal Suppository — RxCUI 1291085
RxNorm drug concept · Semantic clinical drug
RxCUI 1291085
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
21 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1291085
Official nameHydrocortisone acetate 30 MG Rectal Suppository
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped16
Package NDCs mapped21
Reported Medicaid activity (SDUD)913 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Hydrocortisone Rectal: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is used as add-on treatment for ulcerative colitis, especially when it affects the lower or left side of the colon. It is meant to be used along with other supportive measures y...
- It's usually used once at night. Lie on your left side while you use it and for about 30 minutes after. Try to hold it in at least an hour, ideally all night. Your doctor may sugge...
- How do I use it, and how long do I keep it in?
- A usual course is about 21 days, or until you're in remission. Many people feel better within 3 to 5 days. If you use it longer, your doctor will taper you off to every other night...
🕸️ Concept Web — How Hydrocortisone acetate 30 MG Rectal Suppository Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Hydrocortisone acetate 30 MG Rectal Suppository
RxCUI 1291085 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Hydrocortisone
5492IN -
Hydrocortisone acetate
27197PIN
-
Hydrocortisone
-
Brand names 3
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Hemmorex
1674193BN -
Hemril
1291086BN -
Proctocort
202655BN
-
Hemmorex
-
Dose forms 15
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Hydrocortisone Rectal Suppository
370645SCDF -
Hydrocortisone acetate Rectal Suppository
2648780SCDFP -
Hydrocortisone Rectal Product
1164011SCDG -
Hydrocortisone acetate Rectal Product
2659659SCDGP -
Hydrocortisone Rectal Suppository [Hemmorex]
1674195SBDF -
Hydrocortisone Rectal Suppository [Hemril]
1291088SBDF -
Hydrocortisone Rectal Suppository [Proctocort]
367588SBDF -
Hydrocortisone acetate Rectal Suppository [Hemmorex]
2657593SBDFP - +7 more in this family
-
Hydrocortisone Rectal Suppository
-
Clinical & branded drugs 7
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Hydrocortisone acetate 30 MG
1291084SCDC -
Hydrocortisone acetate 30 MG Rectal Suppository [Hemmorex]
1674200SBD -
Hydrocortisone acetate 30 MG Rectal Suppository [Hemril]
1291090SBD -
Hydrocortisone acetate 30 MG Rectal Suppository [Proctocort]
1291092SBD -
Hydrocortisone acetate 30 MG [Hemmorex]
1674199SBDC -
Hydrocortisone acetate 30 MG [Hemril]
1291087SBDC -
Hydrocortisone acetate 30 MG [Proctocort]
1291091SBDC
-
Hydrocortisone acetate 30 MG
Showing up to 8 concepts per family — 20 of 27 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Hydrocortisone acetate 30 MG
SCDC · 1291084 -
Hydrocortisone Rectal Suppository
SCDF · 370645 -
Hydrocortisone acetate Rectal Suppository
SCDFP · 2648780 -
Hydrocortisone Rectal Product
SCDG · 1164011 -
Hydrocortisone acetate Rectal Product
SCDGP · 2659659
Brand-Name Concepts
-
Hydrocortisone acetate 30 MG Rectal Suppository [Hemmorex]
SBD · 1674200 -
Hydrocortisone acetate 30 MG Rectal Suppository [Proctocort]
SBD · 1291092 -
Hydrocortisone acetate 30 MG Rectal Suppository [Hemril]
SBD · 1291090 -
Hydrocortisone acetate 30 MG [Hemmorex]
SBDC · 1674199 -
Hydrocortisone acetate 30 MG [Hemril]
SBDC · 1291087 -
Hydrocortisone acetate 30 MG [Proctocort]
SBDC · 1291091 -
Hydrocortisone Rectal Suppository [Hemmorex]
SBDF · 1674195 -
Hydrocortisone Rectal Suppository [Hemril]
SBDF · 1291088 -
Hydrocortisone Rectal Suppository [Proctocort]
SBDF · 367588 -
Hydrocortisone acetate Rectal Suppository [Hemmorex]
SBDFP · 2657593
📦 FDA Products & Package NDCs
16 products · 21 package NDCs
21 package NDCs map to RxCUI 1291085 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00574-7090-12 | 12 PACKET in 1 BOX (0574-7090-12) / 1 SUPPOSITORY in 1 PACK... | Hydrocortisone Acetate | Padagis US LLC | 1990-07-01 |
| 00574-7093-12 | 12 PACKET in 1 BOX (0574-7093-12) / 1 SUPPOSITORY in 1 PACK... | Hydrocortisone Acetate | Padagis US LLC | 1990-07-01 |
| 00713-0493-12 | 12 PACKET in 1 BOX (0713-0493-12) / 1 SUPPOSITORY in 1 PACK... | Hydrocortisone Acetate | Cosette Pharmaceuticals, Inc. | 2021-08-09 |
| 16477-0202-12 | 12 SUPPOSITORY in 1 BOX (16477-202-12) | Hemmorex-HC | Laser Pharmaceuticals, LLC | 2021-08-02 |
| 16571-0164-21 | 12 SUPPOSITORY in 1 CARTON (16571-164-21) | Hydrocortisone Acetate | Rising Pharma Holdings, Inc. | 2024-03-01 |
| 16571-0676-21 | 12 SUPPOSITORY in 1 CARTON (16571-676-21) | Hydrocortisone Acetate | Rising Pharma Holdings, Inc. | 2021-02-01 |
| 16571-0676-42 | 24 SUPPOSITORY in 1 CARTON (16571-676-42) | Hydrocortisone Acetate | Rising Pharma Holdings, Inc. | 2021-02-01 |
| 24689-0102-01 | 12 SUPPOSITORY in 1 CARTON (24689-102-01) | Hydrocortisone Acetate | APNAR PHARMA LP | 2021-10-01 |
| 24689-0103-01 | 12 SUPPOSITORY in 1 CARTON (24689-103-01) | Hydrocortisone Acetate | APNAR PHARMA LP | 2021-10-01 |
| 39328-0029-12 | 12 SUPPOSITORY in 1 CARTON (39328-029-12) | Hydrocortisone Acetate | Patrin Pharma Inc. | 2022-01-01 |
| 39328-0029-24 | 24 SUPPOSITORY in 1 CARTON (39328-029-24) | Hydrocortisone Acetate | Patrin Pharma Inc. | 2022-01-01 |
| 39328-0129-12 | 12 SUPPOSITORY in 1 CARTON (39328-129-12) | Hydrocortisone Acetate | Patrin Pharma Inc. | 2022-01-01 |
| 63629-2531-01 | 12 PACKET in 1 BOX (63629-2531-1) / 1 SUPPOSITORY in 1 PACK... | Hydrocortisone Acetate | Bryant Ranch Prepack | 2021-04-28 |
| 65649-0511-12 | 12 SUPPOSITORY in 1 BOX (65649-511-12) | Proctocort | Salix Pharmaceuticals, Inc | 2004-06-01 |
| 65649-0511-24 | 24 SUPPOSITORY in 1 BOX (65649-511-24) | Proctocort | Salix Pharmaceuticals, Inc | 2004-06-01 |
| 69367-0243-12 | 12 SUPPOSITORY in 1 CARTON (69367-243-12) | Hydrocortisone Acetate | Westminster Pharmaceuticals, LLC | 2020-02-05 |
| 69367-0243-24 | 24 SUPPOSITORY in 1 CARTON (69367-243-24) | Hydrocortisone Acetate | Westminster Pharmaceuticals, LLC | 2020-02-05 |
| 69367-0260-12 | 12 SUPPOSITORY in 1 CARTON (69367-260-12) | Hydrocortisone Acetate | Westminster Pharmaceuticals, LLC | 2024-11-25 |
| 82568-0150-01 | 12 SUPPOSITORY in 1 CARTON (82568-0150-1) | Hydrocortisone Acetate | AARNA USA INC. | 2026-04-16 |
| 82568-0150-02 | 24 SUPPOSITORY in 1 CARTON (82568-0150-2) | Hydrocortisone Acetate | AARNA USA INC. | 2026-04-16 |
| 82568-0160-01 | 12 SUPPOSITORY in 1 CARTON (82568-0160-1) | Hydrocortisone Acetate | AARNA USA INC. | 2026-04-16 |
Observed labelers:
AARNA USA INC. (3) ·
Patrin Pharma Inc. (3) ·
Rising Pharma Holdings, Inc. (3) ·
Westminster Pharmaceuticals, LLC (3) ·
APNAR PHARMA LP (2) ·
Padagis US LLC (2)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.